Sitting in public-company-listing limbo with a listing deadline on its current stock price, Thousand Oaks-based energy crop producer Ceres will attempt to continue its numerous pricey research projects by balancing them with new revenue streams.
Inogen has benefited from the October release of its Inogen at Home product, which is the lightest continuous-flow oxygen concentrator available to consumers. It successfully floated an additional 2.4 million shares sold by existing stockholders and has announced an expanded credit line with J.P. Morgan Chase.
